C-XON – SB 1.5
Powerful Dual-Action Antibiotic for Severe Bacterial Infections
C-XON SB 1.5 Injection by Citric Labs is a broad-spectrum antibiotic formulation containing Ceftriaxone 1000 mg and Sulbactam Sodium 500 mg per vial. This advanced injectable antibiotic is widely prescribed for the effective treatment of moderate to severe bacterial infections caused by susceptible microorganisms.
The combination of Ceftriaxone, a third-generation cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor, enhances antibacterial activity and helps overcome bacterial resistance for faster and more reliable recovery.
Composition
- Ceftriaxone Sodium IP equivalent to Ceftriaxone – 1000 mg
- Sulbactam Sodium USP equivalent to Sulbactam – 500 mg
Key Benefits
- Broad-spectrum antibacterial action
- Effective against resistant bacterial strains
- Rapid infection control
- Suitable for severe and hospital-acquired infections
- Trusted formulation for critical care management
- Enhanced efficacy with beta-lactamase inhibition
Product Description
C-XON SB 1.5 Injection is specially formulated to provide broad-spectrum antibacterial coverage against gram-positive and gram-negative bacteria. The synergistic combination works effectively in treating respiratory tract infections, urinary tract infections, skin infections, abdominal infections, post-surgical infections, septicemia, and other severe bacterial conditions.
This antibiotic injection is commonly used in hospitals, clinics, and critical care settings due to its fast-acting and reliable therapeutic response.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
